Cell-free DNA liquid biopsy: what to know

It can sometimes identify a molecular change that helps the care team select further testing or treatment. A result must be interpreted alongside the cancer type, imaging, previous pathology and current treatment.

All cells can release small DNA fragments into the bloodstream. A liquid biopsy looks within this cell-free DNA for selected changes associated with tumour cells; this tumour-derived portion is often called circulating tumour DNA.

A detected change may offer useful molecular information without first taking tissue. A result showing no detectable tumour-related change does not exclude cancer: a tumour may release little DNA, or the requested panel may not include its alteration.

Tell the oncology team about previous tumour testing, recent procedures and current treatment so the laboratory request can be matched to the clinical question. Follow the collection centre's instructions for medicines, eating and drinking; do not stop prescribed medicine unless the treating team tells you to.

When the report arrives, confirm whether a change was detected, whether it is considered tumour-related, and whether the finding changes management now. The team may recommend tissue biopsy when the blood result is unclear, negative or needs confirmation in the tumour.

The blood draw usually needs only routine aftercare. Contact the collection service if bleeding at the needle site does not stop with firm pressure, or if increasing redness, swelling, warmth or discharge develops.

Do not wait for a liquid-biopsy report if you develop severe breathlessness, chest pain, new confusion, fainting or heavy bleeding. Seek urgent medical assessment because these symptoms require evaluation on their own.

Ask what specific decision the test is intended to inform, which genes or alterations it examines, and how a negative or uncertain result would be handled. Also ask whether tissue remains available for comparison and who will explain findings that could come from blood-forming cells rather than the tumour.